New Key Statistics Module, Z-Score and F-Score
OCSE:VIRO Key Ratios
| Market Cap kr M | 44.47 |
| Enterprise Value kr M | 37.54 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 3.31 |
| Price/Sales | 4.69 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) kr M | 7.00 |
| EPS (TTM) kr | -2.42 |
| Beneish M-Score | -4.06 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 7.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.90 |
| EV-to-EBITDA | -2.90 |
| PEG | -- |
| Shares Outstanding M | 6.44 |
| Net Margin (%) | -171.56 |
| Operating Margin % | -174.87 |
| Pre-tax Margin (%) | -184.03 |
| Quick Ratio | 10.45 |
| Current Ratio | 13.64 |
| ROA % (ttm) | -71.39 |
| ROE % (ttm) | -105.70 |
| ROIC % (ttm) | -171.23 |
| Dividend Yield % | -- |
| Altman Z-Score | 3.82 |
OCSE:VIRO Number of Guru Trades
OCSE:VIRO Volume of Guru Trades
Gurus Latest Trades with OCSE:VIRO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OCSE:VIRO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers